Saturday, November 1, 2014

Top 5 Managed Healthcare Companies To Buy For 2014

Consumer�� delight has always been the pain of investors. Promotional pricing means good news for consumers as they can bag in more for less money however on the other hand it reduces the margin of the company which results in fall of earning per share consequently share price taking a hit. Diners love Olive Garden�� unlimited breadsticks, but according to an investor, the Italian chain�� parent company, Darden Restaurants, needs to cut back on the carb fest in order to reach peak profitability. Thus it proves that the joy of the two sides of the business the consumer and the investor are inversely proportional.

The shares of Exxon Mobil Corporation (XOM) and Chevron Corp. (CVX) are also somewhat headed in the same downward direction as the investor��joy. Let�� take a better look at what is happening in the world of gas prices.

Top 10 Gas Companies To Buy For 2015: Iron Mountain Incorporated(IRM)

Iron Mountain Incorporated, together with its subsidiaries, provides information management services primarily in North America, Europe, Latin America, and the Asia Pacific. The company offers records management services, including records management program development and implementation based on best-practices to help customers comply with specific regulatory requirements; implementation of policy-based programs that feature storage for various media comprising paper; flexible retrieval access and retention management; hybrid services to help organizations gain control over their paper records; and specialized services for vital records and regulated industries, such as healthcare, energy, government, and financial services. It also provides data protection and recovery services, such as disaster preparedness; off-site vaulting of data backup media for data recovery in the event of a disaster, human error, or virus; online backup and recovery solutions for desktop and la ptop computers, and remote servers; and technology escrow services to protect and manage source code and other proprietary information. In addition, the company offers information destruction services that primarily consist of physical secure shredding operations; and is involved in the shredding of sensitive documents to third-party recyclers. Further, it provides fulfillment services that assemble custom marketing packages and orders, as well as provide reporting on customer marketing literature inventories; and professional consulting services to develop and implement comprehensive records and information management programs. Iron Mountain Incorporated serves commercial, legal, banking, health care, accounting, insurance, entertainment, and government organizations. The company was founded in 1951 and is headquartered in Boston, Massachusetts.

Advisors' Opinion:
  • [By Holly LaFon]

    Singer had also bought debt of Chrysler and Lehman Brothers, and has taken activist equity stakes in Novell and Iron Mountain (IRM).

    He sued his first nation in 1996, when his firm bought defaulted debt of Peru. After a lengthy legal battle and the overturning of a law that stood in his way, Elliott received a $58 million judgment on his $11 million investment, according to Fortune. He has also sued Congo-Brazzaville, Argentina, and several other countries using the controversial tactic that some say disenfranchises the people of the countries with indebted governments.

  • [By Michael Flannelly]

    Early on Friday, information protection and storage services company Iron Mountain Incorporated (IRM) announced that it has acquired Cornerstone Records Management for $191 million in cash.

    Cornerstone Records Management provides record storage, document shredding, and data protection services to small and mid-sized business in the Mid-Atlantic and Northeast regions, as well as the Southern California, Denver, and Houston areas.

    The acquisition of Cornerstone Records Management will help Iron Mountain grow its core information storage business by adding small and mid-sized organizations to its customer base.

    Iron Mountain went on to note that it does not believe this acquisition will provide a meaningful impact in 2013 results. However, it should add $50 to $55 million in revenues in 2014.

    Iron Mountain shares were inactive during pre-market trading on Friday. The stock is down 16.33% year-to-date.

  • [By Ben Levisohn]

    Last week, the IRS gave Iron Mountain (IRM) what it wanted: REIT status. Since then, the storage company’s shares have jumped 18%–and JPMorgan thinks they could head higher.

    AP

    JPMorgan’s Andrew Steinerman and Jeffrey Volshteyn explain why they now rate Iron Mountain Overweight:

    Iron Mountain announced that it achieved IRS approval for REIT status retroactively as of January 1, 2014, completing a process that began in 2012.�Iron Mountain stock leaped 20% on Thursday due to the large cash tax savings and the resulting increased dividend. We still see continued upside due to valuation as yield-oriented and REIT investors are attracted to Iron Mountain. While we recognize that Iron Mountain will not prospectively trade at a full real estate valuation (due to the services side of their business), the REIT structure should help highlight the sizable valuation gap that exists today and should narrow over time.

    Iron Mountain is much cheaper than the industrial, self storage and data center REITs that carry dividend yields of 3.6%, 3.3% and 4.6% respectively. We believe the dividend yields of prison stocks (also non-traditional REITs), which have dividend yields of 6.3%, provide downside protection to Iron Mountain.

    Prison REIT Corrections Corp of America (CXW) yields 6.2% and trades at 24.9 times earnings, while�Geo Group (GEO) yields 6.4% on a P-E ratio of 20.8 times.

    Shares of Iron Mountain have, while Correction Corp of America has and Geo Group has.

  • [By Ben Levisohn]

    Think of Iron Mountain (IRM) as any heavy metal band after Nirvana broke in 1991. Suddenly, a way of playing music that had been wildly successful was looked at as an anachronism and bands like Metallica cut their hair, wore flannel and did just about anything they could think of to fit in in a changed world.

    Getty Images/Lonely Planet Image

    That’s Iron Mountain today. It has a business that was once fantastic–storing paper files for corporations. But in a digital world, that business is pass茅, even if it still brings in tons of money. Sure, Iron Mountain is doing everything it can to change its stripes–offering digital services, trying to morph into a REIT–but Iron Mountain is still what it is.

    And that’s a struggling business.

    On Friday, Iron Mountain released financial results and promptly fell 4.3%, as its earnings and revenue were in line with analyst forecasts but Iron Mountain’s North American storage growth turned negative, perhaps for the first time ever, notes Jefferies’ Dan Dolev and Trevor Young.

    So what now? Dolev and Young don’t think emerging markets can fix what ails Iron Mountain:

    It was encouraging to see international storage internal growth decelerate only slightly (-20bps to +6.3%) as it faced +70bps tougher compares…Is the strength sustainable? We are hopeful, but are not holding our breath given that 1) 4Q storage internal growth in developed international markets (e.g. Western Europe) was already below the FY average (+2.2% vs. +2.5% for the FY), and 2) although 4Q EM storage internal growth accelerated (+13.4% vs. +13.2% for the FY), history suggests that EMs can skip decades of technology evolution and upgrade directly to the newest technology (e.g. smartphones in China).

    Dolev and Young�also doubt Iron Mountain’s M&A strategy. They explain why:

    With FY13 global storage internal growth 3x slower than during the Great Re

Top 5 Managed Healthcare Companies To Buy For 2014: Corning Incorporated(GLW)

Corning Incorporated manufactures and processes specialty glass and ceramics products worldwide. It operates in five segments: Display Technologies, Telecommunications, Environmental Technologies, Specialty Materials, and Life Sciences. The Display Technologies segment manufactures liquid crystal display (LCD) glass for flat panel displays used primarily in notebook computers, flat panel desktop monitors, and LCD televisions. The Telecommunications segment produces optical fiber and cable, and hardware and equipment products, such as cable assemblies, fiber optic hardware, fiber optic connectors, optical components and couplers, closures and pedestals, splice and test equipment, and other accessories for optical connectivity to the telecommunications industry. This segment also offers optical fiber technology products for various applications, such as premises, fiber-to-the-home access, metropolitan, long-haul, and submarine networks. The Environmental Technologies segment manufactures ceramic substrates and filter products for emissions control in mobile and stationary applications. The Specialty Materials segment manufactures products that provide approximately 150 material formulations for glass, glass ceramics, and fluoride crystals used in commercial and industrial markets. The Life Sciences segment provides scientific laboratory products, such as general labware and equipment, as well as tools for cell culture and bioprocess, genomics and proteomics, and high-throughput screening. This segment also develops and produces various technologies, such as the Corning HYPERFlask Cell Culture Vessel for increased cell yields; and other novel surfaces, which include the Corning CellBIND Surface and the Corning Osteo-Assay surface. The company was formerly known as Corning Glass Works and changed its name to Corning Incorporated in April 1989. Corning Incorporated was founded in 1851 and is based in Corning, New York.

Advisors' Opinion:
  • [By Selena Maranjian]

    Let's look at Corning (NYSE: GLW  ) , for example.

    Why Corning?
    The company is a giant in specialty glasses and fiber optics. Its fortunes are influenced these days by smartphone and tablet makers such as Apple (NASDAQ: AAPL  ) , which use its glass in their displays. Corning's Gorilla Glass is so strong that it has put a crimp in the business of screen-protecting companies such as ZAGG (NASDAQ: ZAGG  ) . Some worry about Apple's interest in sapphire, though, as it's even stronger than Gorilla Glass (though more expensive) and could threaten Corning.

  • [By Selena Maranjian]

    Compare to benchmarks
    It's also smart to compare a stock's performance with relevant benchmarks. Think of glass and fiber giant Corning (NYSE: GLW  ) , for example. Many see it as undervalued and have high hopes for its Gorilla Glass and its flexible Willow Glass, but it's also been whacked by a sluggish LCD market. Thus, it has been struggling some in recent years.

  • [By Selena Maranjian]

    Finally, Citadel's biggest closed positions included NetApp�and Newell Rubbermaid. Other closed positions of interest include CenturyLink (NYSE: CTL  ) and Corning (NYSE: GLW  ) . Telecom company CenturyLink has recently been yielding 6.1%, but that reflects a recent dividend cut of about 25% as the company focuses more on share buybacks. It landed a hefty Pentagon contract in April, with a possible 10-year value of $750 million, and has been moving into promising arenas such as cloud computing. The company has substantial debt, topping $19 billion, but also significant free cash flow, near $3 billion annually. Its debt load is lower than some peers, too.

  • [By Brian O'Connell]

    You can�� swing a dead iPhone 4 without hitting a trader or analyst who has a differing outlook on Corning (NYSE: GLW).

    Corning manufactures and sells specialty glasses, ceramics, and related materials worldwide. The company operates through five segments: display technologies, optical communications, environmental technologies, specialty materials, and life sciences.

    But it�� Corning�� tight relationship with Apple (NSDQ: AAPL) that�� causing a stir among investors this week.

    Some say that Apple�� recent embrace of Sapphire, which could replace Corning�� Gorilla Glass as the cover glass for Apple�� next generation of iPhone, is a threat to revenues. That would be a sell trigger for GLW shareholders, they say, as Corning Glass would have trouble replacing the revenue lost from the iPhone deal. (For the record, Apple has made no announcement on Sapphire replacing Gorilla Glass on its iPhones.)

    But there is no shortage of Wall Street watchers who say that Corning is a winner, and can withstand any attack on its Gorilla Glass product line.

    The analytical firm Argus recently hiked its share price outlook on GLW from $20 to $24, citing an accelerated share repurchase agreement with Citibank. The firm also calls for ��ouble-digit earnings per share growth in 2014 and 2015.

    So which is it? Strong share growth based on healthy revenues, or a dip if and when Apple decides to replace Gorilla Glass with Sapphire.?

    Let�� take a look, and see why the naysayers could be wrong about GLW:

    A stronger balance sheet ��Corning�� call last week for an accelerated share repurchasing program should be a good sign for the firm�� share price.

    The rollout, which is ongoing now and will end in the second quarter of 2014, will see Corning buy back outstanding shares worth $1.25 billion.

    According to company financial statements, the buy back program is part of Corning�� $2 billion share repurchas

Top 5 Managed Healthcare Companies To Buy For 2014: Guggenheim Multi-Asset Income ETF (CVY)

The Guggenheim Multi-Asset Income ETF (the Fund), formerly Claymore/Zacks Multi-Asset Income Index ETF, seeks investment results that correspond generally to the performance of an equity index called the Zacks Multi-Asset Income Index (the Index). The Index consists of approximately 125 to 150 securities selected, based on investment and other criteria, from a universe of domestic and international companies. The universe of securities within the Index includes United States-listed common stocks, American depositary receipts (ADRs) paying dividends, real estate investment trusts, master limited partnerships, closed-end funds and traditional preferred stocks. The companies in the universe are selected using a methodology developed by the index provider, Zacks Investment Research, Inc. The Fund, using a passive or indexing investment approach, seeks to replicate the performance of the Index. The Fund�� investment advisor is Claymore Advisors, LLC. Advisors' Opinion:
  • [By Genia Turanova]

    Moreover, investors can do one-stop shopping for most income classes through a single ETF as well. One interesting choice here is Guggenheim Multi-Asset Income (CVY).

Top 5 Managed Healthcare Companies To Buy For 2014: AMAG Pharmaceuticals Inc.(AMAG)

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia (IDA). Its principal product includes Feraheme (ferumoxytol) injection for intravenous (IV) use, which was approved for marketing in the United States in June 2009 by the U.S. Food and Drug Administration, for use as an IV iron replacement therapy for the treatment of IDA in adult patients with chronic kidney disease (CKD). The company is pursuing marketing applications in the European Union, Canada, and Switzerland for Feraheme for the treatment of IDA in CKD patients. AMAG Pharmaceuticals was founded in 1981 and is based in Lexington, Massachusetts.

Advisors' Opinion:
  • [By John Udovich]

    The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:

  • [By Monica Gerson]

    AMAG Pharmaceuticals (NASDAQ: AMAG) shares fell 16% to $18.38 in the pre-market trading after the company received a CRL from the FDA for the supplemental NDA for Feraheme for broader IDA indication.

No comments:

Post a Comment